Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:EDW CVE:FSN CVE:FTE TSE:RBM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas No chart dataCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDW(EDW.V)C$0.00C$0.12▼C$0.32N/AN/A3,696 shs27,500 shsFSN(FSN.V)C$0.00C$0.00▼C$0.00N/AN/AN/AN/AFTE(FTE.V)C$0.00C$0.00▼C$0.00N/AN/AN/AN/ARBMResponse BiomedicalC$0.00C$0.40▼C$1.28N/AN/A1,707 shsN/A7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDW(EDW.V)N/AN/AN/AN/AN/AN/AN/AN/AFSN(FSN.V)N/AN/AN/AN/AN/AN/AN/AN/AFTE(FTE.V)N/AN/AN/AN/AN/AN/AN/AN/ARBMResponse BiomedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDW(EDW.V) 0.00N/AN/AN/AFSN(FSN.V) 0.00N/AN/AN/AFTE(FTE.V) 0.00N/AN/AN/ARBMResponse Biomedical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDW(EDW.V)N/AN/AN/AN/AN/AN/AFSN(FSN.V)N/AN/AN/AN/AN/AN/AFTE(FTE.V)N/AN/AN/AN/AN/AN/ARBMResponse BiomedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDW(EDW.V)N/AN/A0.00N/AN/AN/AN/AN/AN/AFSN(FSN.V)N/AN/A0.00N/AN/AN/AN/AN/AN/AFTE(FTE.V)N/AN/A0.00N/AN/AN/AN/AN/AN/ARBMResponse BiomedicalN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDW(EDW.V)N/AN/AN/AN/AN/AFSN(FSN.V)N/AN/AN/AN/AN/AFTE(FTE.V)N/AN/AN/AN/AN/ARBMResponse BiomedicalN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDW(EDW.V)N/AFSN(FSN.V)N/AFTE(FTE.V)N/ARBMResponse BiomedicalN/AInsider OwnershipCompanyInsider OwnershipEDW(EDW.V)N/AFSN(FSN.V)N/AFTE(FTE.V)N/ARBMResponse BiomedicalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDW(EDW.V)147,000N/AN/ANot OptionableFSN(FSN.V)147,000N/AN/ANot OptionableFTE(FTE.V)147,000N/AN/ANot OptionableRBMResponse Biomedical5N/AN/ANot OptionableRBM, EDW, FSN, and FTE HeadlinesRecent News About These CompaniesBiomedical Tester Market is Estimated to Reach at a US$ 1.9 Bn in 2022September 14, 2022 | fmiblog.comFScott Wins 2022 Biomedical Engineering Society Mid-Career AwardSeptember 14, 2022 | mccormick.northwestern.eduMImmuno-oncology treatment pre-surgery safe and effective option for localized non-small cell lung cancerSeptember 14, 2022 | medicalxpress.comMAfrica: RBM Partnership Welcomes the Latest Malaria Vaccine DevelopmentsSeptember 13, 2022 | allafrica.comBisk Announces Contract Renewal with the USF Health Morsani College of MedicineAugust 25, 2022 | apnews.comAFDA warns Emergent BioSolutions over GMP violations at Camden facilityAugust 16, 2022 | raps.orgRPOINT Biopharma Reports Second Quarter 2022 Financial Results and Provides Business HighlightsAugust 12, 2022 | apnews.comANIH updates Hepatitis B Strategic Research PlanAugust 1, 2022 | medicalxpress.comMGlobal Genomic Cancer Panel and Profiling Market Research Report 2022July 28, 2022 | finance.yahoo.comA novel COVID-19 vaccine using modified bacterial DNAJuly 23, 2022 | medicalxpress.comMShortage of malaria vaccines for kids who need it mostJuly 19, 2022 | thestar.com.myTMolecular Diagnostics for Cancer Market Report 2022: Featuring Key Players Abbott Diagnostics, Bristol-Myers Squibb, Janssen Diagnostics & OthersJuly 9, 2022 | finance.yahoo.comEmergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for EbolaJuly 7, 2022 | finance.yahoo.comEmergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment ...July 7, 2022 | bakersfield.comBEmergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine CandidateJune 24, 2022 | yahoo.comRwanda: World Leaders Gather At the Kigali Summit On Malaria and Neglected Tropical Diseases to Unlock the Potential for a Healthier WorldJune 24, 2022 | allafrica.comRwanda: Commonwealth Leaders 'To Make Bold Commitments' on Malaria, NTDsJune 23, 2022 | allafrica.comCommonwealth leaders ‘to make bold commitments’ on Malaria, NTDsJune 22, 2022 | newtimes.co.rwNDelveInsight Business Research, LLP: Age-related Macular Degeneration Market to Progress at a CAGR of 3.4% by 2032 | DelveInsightJune 15, 2022 | finanznachrichten.deAge-related Macular Degeneration Market to...June 15, 2022 | benzinga.comRBM, EDW, FSN, and FTE Company Descriptions(EDW.V) CVE:EDWEdgewater Exploration Ltd. is a Canada-based company, which is engaged in the mineral property exploration and development business. The Company's business is the acquisition, exploration, evaluation, and development of mineral resource properties. The Company's project, Corcoesto Gold Project, is a late-stage exploration gold project located in the extreme northwest corner of Spain, within La Coruna Province (Galician Community). The property includes approximately three exploitation concessions covering approximately 773.6 hectares of surface area that are owned by Mineira de Corcoesto, S.L., a subsidiary of the Company. The Corcoesto deposit is located within the boundaries of the Ciudad de Masma, Ciudad de Landro and Emilita exploitation concessions. The Company has not generated any revenues.(FSN.V) CVE:FSNFranchise Services of North America Inc. is a car rental franchisor in North America. The Company operates in the car, van and light truck rental space, alongside a range of insurance products, both business and personal, to its franchisees, the automobile industry and consumers. It operates through its subsidiary, U-Save Auto Rental of America Inc. (U-Save). Its segments include Franchise, Insurance and Other. The Franchise segment is engaged in franchising to operate U-Save Auto Rental businesses in the United States. The Insurance segment is engaged in providing franchisees and independent auto rental operators with financial services related to insurance products in the United States. It owns and operates various brands, including U-Save Car & Truck Rental, U-Save Car Sales, Auto Rental Resource Center (ARRC), Xpress Rent-A-Car and Peakstone Financial Services. U-Save licenses franchises to operate U-Save Auto Rental and U-Save Car & Truck Rental businesses across the world.(FTE.V) CVE:FTEResponse Biomedical TSE:RBMResponse Biomedical Corp. (Response) offers diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets. The Company operates through the research, development, commercialization and distribution of diagnostic technologies segment. The Company develops, manufactures and sells its RAMP system for the global medical point of care market, including cardiovascular testing, infectious disease testing market and the on-site environmental testing market, including biodefense and vector environmental testing. In the United States, its RAMP 200 Reader is limited to central-lab use with the cardiovascular tests. POC, on-site diagnostic tests (or assays) are non-laboratory-based tests performed using portable hand-held devices, compact desktop analyzers, single-use test cartridges and/or dipsticks. The Company's RAMP system is a platform technology that combines a fluorescence detection system with lateral flow immunoassays. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.